Filing Details

Accession Number:
0000950170-24-059787
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-14 17:16:13
Reporting Period:
2024-05-10
Accepted Time:
2024-05-14 17:16:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1237831 Globus Medical Inc GMED Surgical & Medical Instruments & Apparatus (3841) 043744954
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1478479 Dan Lemaitre Valley Forge Business Center
2560 General Armistead Avenue
Audubon PA 19403
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2024-05-10 17,500 $43.77 28,300 No 4 M Direct
Class A Common Stock Acquisiton 2024-05-10 17,500 $43.58 45,800 No 4 M Direct
Class A Common Stock Acquisiton 2024-05-10 17,500 $53.27 63,300 No 4 M Direct
Class A Common Stock Disposition 2024-05-10 63,300 $64.61 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Stock Option (Right to Buy Class A Common Stock) Disposition 2024-05-10 17,500 $0.00 17,500 $43.77
Class A Common Stock Stock Option (Right to Buy Class A Common Stock) Disposition 2024-05-10 17,500 $0.00 17,500 $43.58
Class A Common Stock Stock Option (Right to Buy Class A Common Stock) Disposition 2024-05-10 17,500 $0.00 17,500 $53.27
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2028-01-22 No 4 M Direct
0 2029-01-22 No 4 M Direct
0 2030-01-22 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.80 to $64.68, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
  2. These options were granted on January 22, 2018 and are fully vested.
  3. These options were granted on January 22, 2019 and are fully vested.
  4. These options were granted on January 22, 2020 and are fully vested.